Georgia NCI Community Oncology Research Program
CLOSER TO HOME
A novel research program puts cutting-edge treatments and studies within reach of more Georgians
THE PROBLEM: For cancer care to improve in our state, more Georgians must be able to participate in promising new treatments or studies that help prevent and control cancer.
Such programs are typically offered in cancer centers in high-populated areas; so historically, they’ve been out of reach to many Georgians. And in places where they were offered, many under-served populations weren’t aware they existed.
A bridge was needed between these residents and our state’s cancer centers to get more Georgians involved in new cancer treatments and activities that help detect or prevent cancer. That bridge is GA NCORP.
THE PROGRAM: GA NCORP is part of a larger national effort developed by the National Cancer Institute, or NCI.
In August 2014, NCI selected Georgia as an NCORP (NCI Community Oncology Research Program) community site, awarding a five-year grant of nearly $6 million to Northside Hospital Cancer Institute.
To develop the program, Northside partners with:
- the Nancy N. and J.C. Lewis Cancer & Research Pavilion at St. Joseph’s/Candler in Savannah. Northside and St. Joseph’s/Candler are Georgia’s largest community oncology clinical trial programs.
- Georgia CORE, which coordinates the participation of four network affiliates — John B. Amos Cancer Center (Columbus), Harbin Clinic (Rome), Navicent Health (Macon) and Northeast Georgia Medical Center (Gainesville).
1. Get more eligible Georgians to participate in cancer clinical trials in their own communities by increasing awareness of treatment options
2. Reduce cancer care disparities by enrolling more underrepresented populations of Georgians in all kinds of studies and settings
3. Balance the portfolio of research among open studies for treatment and cancer prevention and control studies
4. Get more healthcare providers in Georgia CORE’s network to participate in GA NCORP careand research
So far, GA NCORP is creating a constellation of participation in cutting-edge studies and treatments.
In the program’s fifth year, 7 out of 10 Georgians are now within reach of new prevention, control and treatment trials. Many are in rural and underserved communities.
THE ADDED BENEFIT
Physicians and scientists conducting studies need broad populations to participate, so that results will be more precise and beneficial. By engaging Georgians from all geographic areas and backgrounds, GA NCORP makes the work of these researchers more relevant and valuable.
GA NCORP has:
- Built a network of 100 physicians with access to dozens of studies – in treatment, prevention and control – available in 41 locations across the state
- Far exceeded national averages in the percentage of rural residents and racial/ethnic minorities enrolled in clinical treatments and other studies
- Ranked in the top quartile nationally for achieving goals
- Opened and recruited participants in five new studies in cancer care delivery research
- Developed and presented a new concept for genomics research
- Ranked in the top 15 sites nationally for enrolling patients in 11 high-priority clinical trials
- Received NCI’s Platinum Certificate of Excellence Award for exceptional achievement in enrolling patients in trials
Because of GA NCORP, 1,800 more Georgians have participated in new clinical treatments and other studies – all approved by the National Cancer Institute.